The Phase 1 trial of the second-generation triterpenoid antifungal SCY-247, initiated in December of 2024, continues and results are expected in Q3 of 2025.Four presentations for SCY-247 were accepted ...
This is the second outbreak of the highly contagious illness on a Princess voyage in 2025 so far. A Princess Cruises ship has ...
The spread of H5N1 bird flu has sickened dozens of Americans, resulted in a nationwide egg shortage and led to the deaths of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback